We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.74B
AUM Growth
+$18.9M
Cap. Flow
-$61.5M
Cap. Flow %
-3.53%
Top 10 Hldgs %
23.9%
Holding
276
New
11
Increased
44
Reduced
193
Closed
16

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$13M
2
DOCS icon
Doximity
DOCS
+$10.2M
3
LOB icon
Live Oak Bancshares
LOB
+$7.32M
4
RXO icon
RXO
RXO
+$7.31M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.78M

Top Sells

Rank Stock Value
1
AERI
Aerie Pharmaceuticals
AERI
+$24.3M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$12.4M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$12.3M
4
XPO icon
XPO
XPO
+$7.84M
5
RXT icon
Rackspace Technology
RXT
+$5.42M

Sector Composition

Rank Sector Weight
1 Technology 27.01%
2 Healthcare 26.13%
3 Industrials 15.45%
4 Consumer Discretionary 11.41%
5 Communication Services 6.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKY icon
201
Champion Homes
SKY
$5.06B
$1.73M 0.1%
33,647
-4,624
-12% -$246K
SSTI icon
202
SoundThinking
SSTI
$102M
$1.71M 0.1%
50,686
-1,070
-2% -$35.8K
DOV icon
203
Dover
DOV
$28.4B
$1.68M 0.1%
12,415
-222
-2% -$29.5K
CIEN icon
204
Ciena
CIEN
$58B
$1.68M 0.1%
32,873
-522
-2% -$23.6K
CSCO icon
205
Cisco
CSCO
$489B
$1.67M 0.1%
34,967
-4,702
-12% -$214K
RXT icon
206
Rackspace Technology
RXT
$1.27B
$1.66M 0.1%
561,997
-1,283,841
-70% -$5.42M
CODA icon
207
Coda Octopus Group
CODA
$121M
$1.63M 0.09%
237,805
-4,893
-2% -$30.9K
PBYI icon
208
Puma Biotechnology
PBYI
$444M
$1.62M 0.09%
383,218
-4,321
-1% -$14.9K
SWI
209
DELISTED
SolarWinds Corporation Common Stock
SWI
$1.61M 0.09%
172,492
+27,107
+19% +$237K
TVTX icon
210
Travere Therapeutics
TVTX
$5.82B
$1.6M 0.09%
76,208
-1,629
-2% -$34.5K
IEX icon
211
IDEX
IEX
$17.3B
$1.6M 0.09%
7,014
-2,063
-23% -$461K
QRHC icon
212
Quest Resource Holding
QRHC
$30.6M
$1.56M 0.09%
+255,313
New +$1.9M
DVN icon
213
Devon Energy
DVN
$49.2B
$1.55M 0.09%
25,226
-2,400
-9% -$164K
SITM icon
214
SiTime
SITM
$22.2B
$1.5M 0.09%
+14,809
New +$1.4M
OPTN
215
DELISTED
OptiNose
OPTN
$1.5M 0.09%
53,967
-753
-1% -$28.6K
MATX icon
216
Matsons
MATX
$6.19B
$1.5M 0.09%
23,943
-2,469
-9% -$163K
EW icon
217
Edwards Lifesciences
EW
$52.7B
$1.49M 0.09%
19,996
-4,224
-17% -$326K
OMCL icon
218
Omnicell
OMCL
$1.69B
$1.43M 0.08%
28,361
-1,961
-6% -$118K
FLWS icon
219
1-800-Flowers.com
FLWS
$254M
$1.43M 0.08%
149,410
-9,926
-6% -$78.8K
ARAY icon
220
Accuray
ARAY
$35.2M
$1.43M 0.08%
682,794
-21,622
-3% -$44.7K
DLB icon
221
Dolby
DLB
$5.81B
$1.39M 0.08%
19,648
-245
-1% -$16.9K
NVDA icon
222
NVIDIA
NVDA
$5.38T
$1.38M 0.08%
94,660
-17,340
-15% -$254K
GBCI icon
223
Glacier Bancorp
GBCI
$6.32B
$1.3M 0.07%
26,317
-1,049
-4% -$56.6K
EBAY icon
224
eBay
EBAY
$47.5B
$1.29M 0.07%
31,202
-442
-1% -$18.3K
CDW icon
225
CDW
CDW
$17.1B
$1.28M 0.07%
7,180
-1,373
-16% -$241K
7 8
9
10 11

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Rice Hall James & Associates held 276 positions worth $1.74B, up 1.1% from $1.72B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $61.5M in Q4 2022, closing 16 positions and reducing 193 holdings. Its most notable exit was Aerie Pharmaceuticals, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in OmniAb worth $8.94M.

  • Rice Hall James & Associates's largest Q4 2022 buy was OmniAb: 2,483,766 shares worth $8.94M.
  • Rice Hall James & Associates added most to Doximity in Q4 2022, an estimated $10.2M increase.
  • Rice Hall James & Associates's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $12.3M.
  • Rice Hall James & Associates fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $24.3M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.74B portfolio in Q4 2022.
  • Rice Hall James & Associates opened 11 new positions and closed 16 in Q4 2022.
  • Rice Hall James & Associates's portfolio value rose 1.1% quarter-over-quarter to $1.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2022, filed 27 Jan 2023.